Oramed Pharmaceuticals annual gross margin
2016
2017
2019
2025
Oramed Pharmaceuticals Gross Margin Growth & History (ORMP)
Oramed Pharmaceuticals's gross margin was 0.65% for fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 0.65% | — |
| 2019 | 2019-08-31 | 96.67% | — |
| 2017 | 2017-08-31 | 92.39% | +68.83 pp |
| 2016 | 2016-08-31 | 23.56% | — |
Oramed Pharmaceuticals quarterly gross margin
Q2.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.19
Q2.19
Q3.19
Q4.19
Q1.25
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | 0.65% | — |
| Q4 2019 | 2019-08-31 | 100.00% | — |
| Q3 2019 | 2019-05-31 | 100.00% | — |
| Q2 2019 | 2019-02-28 | 91.74% | — |
| Q1 2019 | 2018-11-30 | 94.81% | — |
| Q4 2017 | 2017-08-31 | 100.00% | — |
| Q3 2017 | 2017-05-31 | 100.00% | — |
| Q2 2017 | 2017-02-28 | 100.00% | +3.20 pp |
| Q1 2017 | 2016-11-30 | 69.34% | — |
| Q2 2016 | 2016-02-29 | 96.80% | — |
Oramed Pharmaceuticals gross margin trends
Between the periods ended 2016-08-31 and 2025-12-31, Oramed Pharmaceuticals's gross margin decreased from 23.56% to 0.65%, a change of −22.91 percentage points. The latest reported quarter, Q1 2025, shows 0.65%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals source filings ↗